GEHC
$69.00-1.76%
as of close, Oct 21, 2026
☾ AH $69.00 -1.76%
GE HealthCare Technologies Inc. Common StockStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPNasdaq-100 · 0.1% of QQQNasdaq Composite · 0.06% of ONEQS&P 500 · 0.05% of SPYRussell 1000 · 0.04% of IWBUS Stock Market · 0.04% of VTIRussell 3000 · 0.04% of IWVMSCI World · 0.03% of URTHMSCI ACWI · 0.03% of ACWI
GEHC SEC filings (2026)
CIK 1932393 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844) · incorporated in DE · fiscal year ends in December
442 filings on EDGAR since 2022 · 4 annual, 11 quarterly, 55 current · financial statements · earnings
Latest 10-K
Feb 4, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Jul 29, 2026
quarter to Jun 30, 2026
Latest 8-K
Sep 22, 2026
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
Last earnings release
Jul 29, 2026
$1.13 vs $1.04 · ▲ 12.2%
Filings on file
442
since 2022, 268 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 228-K8-K · GE HealthCare appoints veteran finance executive Pascal Desroches to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
August 2026
- Aug 188-K8-K · GE HealthCare appoints William Grogan as Chief Financial OfficerDirectors or officers; compensation
July 2026
- Jul 29EarningsEarnings release — EPS $1.13 vs $1.04 est. (+8.7%); revenue $5.29B (+6% y/y) 12.2%
- Jul 29ReportQuarterly report, Q2 2026 — revenue $5.29B (+6% y/y), net income $561.0M, EPS $1.24
- Jul 298-K8-K · Regulation FD disclosure
- Jul 238-K8-K · GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentumResults of operations; Directors or officers; compensation
May 2026
- May 22Insider buyLobo Kevin (Director) bought 10,000 shares for $642K at $64.18
- May 12Insider buyHochman Rodney F (Director) bought 1,618 shares for $100K at $62.03
- May 118-K8-K · Shareholder vote results; Other events
- May 8Insider buyYang Watkin Phoebe L. (Director) bought 1,000 shares for $63K at $63.01
- May 6Insider buyCULP H LAWRENCE JR (Director) bought 80,805 shares for $5.0M at $61.88
- May 6Insider buyStromberg William J (Director) bought 1,000 shares for $62K at $61.69
- May 1Insider buySACCARO JAMES (Chief Financial Officer) bought 3,310 shares for $201K at $60.60
April 2026
- Apr 30Insider buyArduini Peter J (President and CEO · Director) bought 4,169 shares for $250K at $59.93
- Apr 30Insider buyJimenez Frank R (GC & Corporate Secretary) bought 1,750 shares for $106K at $60.45
- Apr 29EarningsEarnings release — EPS $0.99 vs $1.07 est. (−7.5%); revenue $5.13B (+7% y/y) 13.2%
- Apr 29ReportQuarterly report, Q1 2026 — revenue $5.13B (+7% y/y), net income $389.0M, EPS $0.85
March 2026
- Mar 19ProxyProxy · Annual report to shareholders
- Mar 19ProxyProxy · Additional proxy materials
- Mar 19ProxyProxy · Proxy statement
- Mar 178-K8-K · GE HealthCare appoints medtech leader Kevin Lobo to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
February 2026
December 2025
- Dec 158-K8-K · Material definitive agreement; New financial obligation; Other events
- Dec 28-K8-K · Other events
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold nothing and bought $6.4M in 8 purchases; 71 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| May 22, 2026Form 4 | Lobo KevinDirectorBought · $642K · 10,000 sh |
| May 12, 2026Form 4 | Hochman Rodney FDirectorBought · $100K · 1,618 sh |
| May 8, 2026Form 4 | Yang Watkin Phoebe L.DirectorBought · $63K · 1,000 sh |
| May 6, 2026Form 4 | CULP H LAWRENCE JRDirectorBought · $5.0M · 80,805 sh |
| May 6, 2026Form 4 | Stromberg William JDirectorBought · $62K · 1,000 sh |
| May 1, 2026Form 4 | SACCARO JAMESChief Financial OfficerBought · $201K · 3,310 sh |
| Apr 30, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorBought · $250K · 4,169 sh |
| Apr 30, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryBought · $106K · 1,750 sh |
Awards, exercises, withholding and plan purchases · 71 transactions
| Date | Insider |
|---|---|
| Sep 14, 2026Form 4 | Grogan William KChief Financial OfficerAward · $0 · 75,096 sh |
| Sep 14, 2026Form 4 | Grogan William KChief Financial OfficerAward · Employee Stock Option (rig… · $0 · 31,877 sh |
| Sep 3, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorTax withholding · $445K · 6,303 sh |
| Sep 3, 2026Form 4 | Kass-Hout TahaChief Technology OfficerTax withholding · $106K · 1,502 sh |
| Sep 3, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryTax withholding · $104K · 1,480 sh |
| Sep 3, 2026Form 4 | Rackliffe PhilipCEO, AISTax withholding · $56K · 798 sh |
| Sep 3, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxTax withholding · $51K · 718 sh |
| Sep 3, 2026Form 4 | Holton Adam YChief People OfficerTax withholding · $47K · 673 sh |
| Sep 3, 2026Form 4 | Estrampes CatherineChief Commer. & Growth OfficerTax withholding · $36K · 508 sh |
| Sep 3, 2026Form 4 | Newcomb George A.Chief Accounting OfficerTax withholding · $7,903 · 112 sh |
| Sep 1, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorTax withholding · $820K · 11,515 sh |
| Sep 1, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryTax withholding · $223K · 3,131 sh |
| Sep 1, 2026Form 4 | Kass-Hout TahaChief Technology OfficerTax withholding · $209K · 2,940 sh |
| Sep 1, 2026Form 4 | Bankes JeannetteCEO, Patient Care SolutionsTax withholding · $76K · 1,064 sh |
| Sep 1, 2026Form 4 | Rackliffe PhilipCEO, AISTax withholding · $61K · 856 sh |
| Sep 1, 2026Form 4 | Holton Adam YChief People OfficerTax withholding · $47K · 659 sh |
| Aug 15, 2026Form 4 | Holton Adam YChief People OfficerTax withholding · $100K · 1,360 sh |
| May 15, 2026Form 4 | Bankes JeannetteCEO, Patient Care SolutionsTax withholding · $347K · 5,535 sh |
| May 15, 2026Form 4 | Rackliffe PhilipCEO, AISAward · $0 · 16,458 sh |
| May 7, 2026Form 4 | CULP H LAWRENCE JRDirectorAward · $0 · 7,743 sh |
| May 7, 2026Form 4 | Hochman Rodney FDirectorAward · $0 · 6,275 sh |
| May 7, 2026Form 4 | Madden Anne TDirectorAward · $0 · 5,868 sh |
| May 7, 2026Form 4 | LESJAK CATHERINE ADirectorAward · $0 · 3,586 sh |
| May 7, 2026Form 4 | Stromberg William JDirectorAward · $0 · 3,586 sh |
| May 7, 2026Form 4 | Lobo KevinDirectorAward · $0 · 3,586 sh |
| May 7, 2026Form 4 | Yang Watkin Phoebe L.DirectorAward · $0 · 3,586 sh |
| Mar 13, 2026Form 4 | Lobo KevinDirectorAward · $0 · 777 sh |
| Mar 2, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorAward · Employee Stock Option (rig… · $0 · 129,140 sh |
| Mar 2, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorAward · $0 · 49,120 sh |
| Mar 2, 2026Form 4 | Kass-Hout TahaChief Technology OfficerAward · Employee Stock Option (rig… · $0 · 34,847 sh |
| Mar 2, 2026Form 4 | SACCARO JAMESChief Financial OfficerAward · Employee Stock Option (rig… · $0 · 32,797 sh |
| Mar 2, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryAward · Employee Stock Option (rig… · $0 · 28,697 sh |
| Mar 2, 2026Form 4 | Rackliffe PhilipCEO, AVSAward · Employee Stock Option (rig… · $0 · 24,598 sh |
| Mar 2, 2026Form 4 | Rott RolandCEO, ImagingAward · Employee Stock Option (rig… · $0 · 22,548 sh |
| Mar 2, 2026Form 4 | Bankes JeannetteCEO, Patient Care SolutionsAward · Employee Stock Option (rig… · $0 · 18,038 sh |
| Mar 2, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxAward · Employee Stock Option (rig… · $0 · 17,218 sh |
| Mar 2, 2026Form 4 | Holton Adam YChief People OfficerAward · Employee Stock Option (rig… · $0 · 14,348 sh |
| Mar 2, 2026Form 4 | Kass-Hout TahaChief Technology OfficerAward · $0 · 13,254 sh |
| Mar 2, 2026Form 4 | SACCARO JAMESChief Financial OfficerAward · $0 · 12,475 sh |
| Mar 2, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryAward · $0 · 10,915 sh |
| Mar 2, 2026Form 4 | Rackliffe PhilipCEO, AVSAward · $0 · 9,356 sh |
| Mar 2, 2026Form 4 | Rott RolandCEO, ImagingAward · $0 · 8,576 sh |
| Mar 2, 2026Form 4 | Bankes JeannetteCEO, Patient Care SolutionsAward · $0 · 6,861 sh |
| Mar 2, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxAward · $0 · 6,549 sh |
| Mar 2, 2026Form 4 | Holton Adam YChief People OfficerAward · $0 · 5,457 sh |
| Mar 2, 2026Form 4 | Newcomb George A.Chief Accounting OfficerAward · Employee Stock Option (rig… · $0 · 3,443 sh |
| Mar 2, 2026Form 4 | Newcomb George A.Chief Accounting OfficerAward · $0 · 1,309 sh |
| Feb 12, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorTax withholding · $2.6M · 33,445 sh |
| Feb 12, 2026Form 4 | SACCARO JAMESChief Financial OfficerTax withholding · $679K · 8,570 sh |
| Feb 12, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryTax withholding · $662K · 8,357 sh |
| Feb 12, 2026Form 4 | Kass-Hout TahaChief Technology OfficerTax withholding · $617K · 7,787 sh |
| Feb 12, 2026Form 4 | Rott RolandCEO, ImagingTax withholding · $312K · 3,943 sh |
| Feb 12, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxTax withholding · $258K · 3,261 sh |
| Feb 12, 2026Form 4 | Rackliffe PhilipCEO, AVSTax withholding · $93K · 1,174 sh |
| Feb 12, 2026Form 4 | Newcomb George A.Chief Accounting OfficerTax withholding · $64K · 802 sh |
| Feb 12, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorAward · $0 · 74,908 sh |
| Feb 12, 2026Form 4 | Kass-Hout TahaChief Technology OfficerAward · $0 · 23,339 sh |
| Feb 12, 2026Form 4 | SACCARO JAMESChief Financial OfficerAward · $0 · 22,610 sh |
| Feb 12, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryAward · $0 · 22,078 sh |
| Feb 12, 2026Form 4 | Rott RolandCEO, ImagingAward · $0 · 7,885 sh |
| Feb 12, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxAward · $0 · 6,938 sh |
| Feb 12, 2026Form 4 | Rackliffe PhilipCEO, AVSAward · $0 · 3,154 sh |
| Feb 12, 2026Form 4 | Newcomb George A.Chief Accounting OfficerAward · $0 · 2,523 sh |
| Feb 1, 2026Form 4 | Arduini Peter JPresident and CEO · DirectorTax withholding · $253K · 3,210 sh |
| Feb 1, 2026Form 4 | SACCARO JAMESChief Financial OfficerTax withholding · $75K · 948 sh |
| Feb 1, 2026Form 4 | Jimenez Frank RGC & Corporate SecretaryTax withholding · $75K · 947 sh |
| Feb 1, 2026Form 4 | Kass-Hout TahaChief Technology OfficerTax withholding · $67K · 847 sh |
| Feb 1, 2026Form 4 | Rott RolandCEO, ImagingTax withholding · $44K · 558 sh |
| Feb 1, 2026Form 4 | O'Neill Kevin MichaelCEO, PDxTax withholding · $36K · 462 sh |
| Feb 1, 2026Form 4 | Rackliffe PhilipCEO, AVSTax withholding · $15K · 189 sh |
| Feb 1, 2026Form 4 | Newcomb George A.Chief Accounting OfficerTax withholding · $8,529 · 108 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 16 filings
| Filed | What it is |
|---|---|
| Sep 22, 20268-K | GE HealthCare appoints veteran finance executive Pascal Desroches to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Aug 18, 20268-K | GE HealthCare appoints William Grogan as Chief Financial OfficerDirectors or officers; compensation |
| Jul 29, 20268-K | Regulation FD disclosure |
| Jul 29, 202610-Q | Quarterly report, Q2 2026 — revenue $5.29B (+6% y/y), net income $561.0M, EPS $1.24 |
| Jul 29, 20268-K | Earnings release — EPS $1.13 vs $1.04 est. (+8.7%); revenue $5.29B (+6% y/y) 12.2% |
| Jul 23, 20268-K | GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentumResults of operations; Directors or officers; compensation |
| May 11, 20268-K | Shareholder vote results; Other events |
| Apr 29, 202610-Q | Quarterly report, Q1 2026 — revenue $5.13B (+7% y/y), net income $389.0M, EPS $0.85 |
| Apr 29, 20268-K | Earnings release — EPS $0.99 vs $1.07 est. (−7.5%); revenue $5.13B (+7% y/y) 13.2% |
| Mar 19, 2026ARS | Annual report to shareholders |
| Mar 19, 2026DEFA14A | Additional proxy materials |
| Mar 19, 2026DEF 14A | Proxy statement |
| Mar 17, 20268-K | GE HealthCare appoints medtech leader Kevin Lobo to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Feb 27, 20268-K | Material definitive agreement; Termination of a material agreement; New financial obligation |
| Feb 4, 202610-K | Annual report, FY2025 — revenue $20.63B (+5% y/y), net income $2.08B, EPS $4.55 |
| Feb 4, 20268-K | Earnings release — EPS $1.44 vs $1.43 est. (+0.7%); revenue $5.70B (+7% y/y) 4.9% |
2025 · 18 filings
| Filed | What it is |
|---|---|
| Dec 15, 20258-K | Material definitive agreement; New financial obligation; Other events |
| Dec 2, 20258-K | Other events |
| Oct 29, 202510-Q | Quarterly report, Q3 2025 — revenue $5.14B (+6% y/y), net income $446.0M, EPS $0.98 |
| Oct 29, 20258-K | Earnings release — EPS $1.07 vs $1.05 est. (+1.9%); revenue $5.14B (+6% y/y) 2.5% |
| Jul 30, 202510-Q | Quarterly report, Q2 2025 — revenue $5.01B (+3% y/y), net income $486.0M, EPS $1.06 |
| Jul 30, 20258-K | Earnings release — EPS $1.06 vs $0.91 est. (+16.5%); revenue $5.01B (+3% y/y) 7.8% |
| Jul 24, 20258-K | Directors or officers; compensation |
| Jun 9, 20258-K | Other events |
| Jun 4, 20258-K | Other events |
| May 30, 20258-K | Shareholder vote results |
| Apr 30, 202510-Q | Quarterly report, Q1 2025 — revenue $4.78B (+3% y/y), net income $564.0M, EPS $1.23 |
| Apr 30, 20258-K | Earnings release — EPS $1.01 vs $0.91 est. (+11.0%); revenue $4.78B (+3% y/y) 3.3% |
| Apr 10, 2025ARS | Annual report to shareholders |
| Apr 10, 2025DEFA14A | Additional proxy materials |
| Apr 10, 2025DEF 14A | Proxy statement |
| Mar 31, 20258-K | Material definitive agreement; Termination of a material agreement; New financial obligation |
| Feb 13, 202510-K | Annual report, FY2024 — revenue $19.67B (+1% y/y), net income $1.99B, EPS $4.34 |
| Feb 13, 20258-K | Earnings release — EPS $1.45 vs $1.26 est. (+15.1%); revenue $5.32B (+2% y/y) 8.8% |
2024 · 25 filings
| Filed | What it is |
|---|---|
| Dec 12, 20248-K | Material definitive agreement; New financial obligation |
| Nov 21, 20248-K | Regulation FD disclosure |
| Nov 8, 20248-K | Other events |
| Oct 30, 20248-K | Regulation FD disclosure |
| Oct 30, 202410-Q | Quarterly report, Q3 2024 — revenue $4.86B (+1% y/y), net income $470.0M, EPS $1.02 |
| Oct 30, 20248-K | Earnings release — EPS $1.14 vs $1.06 est. (+7.5%); revenue $4.86B (+1% y/y) 2.3% |
| Sep 13, 20248-K | Other events |
| Aug 15, 20248-K | Other events |
| Aug 9, 20248-K | Other events |
| Jul 31, 202410-Q | Quarterly report, Q2 2024 — revenue $4.84B (+0% y/y), net income $428.0M, EPS $0.93 |
| Jul 31, 20248-K | Earnings release — EPS $1.00 vs $0.98 est. (+2.0%); revenue $4.84B (+0% y/y) 2.4% |
| May 23, 20248-K | Shareholder vote results |
| Apr 30, 202410-Q | Quarterly report, Q1 2024 — revenue $4.65B (−1% y/y), net income $374.0M, EPS $0.81 |
| Apr 30, 20248-K | Earnings release — EPS $0.90 vs $0.90 est.; revenue $4.65B (−1% y/y) 14.3% |
| Apr 15, 20248-K | Directors or officers; compensation |
| Apr 4, 2024ARS | Annual report to shareholders |
| Apr 4, 2024DEFA14A | Additional proxy materials |
| Apr 4, 2024DEF 14A | Proxy statement |
| Mar 14, 20248-K | Other events |
| Feb 16, 20248-K | Other events |
| Feb 6, 20248-K/A | Earnings release — EPS $1.18 vs $1.07 est. (+10.3%); revenue $5.21B (+5% y/y) 11.6% |
| Feb 6, 20248-K/A | Earnings release — EPS $1.18 vs $1.07 est. (+10.3%); revenue $5.21B (+5% y/y) 11.6% |
| Feb 6, 202410-K | Annual report, FY2023 — revenue $19.55B (+7% y/y), net income $1.57B, EPS $3.03 |
| Feb 6, 20248-K | Earnings release — EPS $1.18 vs $1.07 est. (+10.3%); revenue $5.21B (+5% y/y) 11.6% |
| Feb 5, 20248-K | Directors or officers; compensation |
2023 · 20 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 31, 202310-Q | Quarterly report, Q3 2023 — revenue $4.82B (+5% y/y), net income $375.0M, EPS $0.82 |
| Jul 25, 202310-Q | Quarterly report, Q2 2023 — revenue $4.82B (+7% y/y), net income $418.0M, EPS $0.91 |
| Apr 25, 202310-Q | Quarterly report, Q1 2023 — revenue $4.71B (+8% y/y), net income $372.0M, EPS $0.41 |
| Apr 5, 2023ARS | Annual report to shareholders |
| Apr 5, 2023DEFA14A | Additional proxy materials |
| Apr 5, 2023DEF 14A | Proxy statement |
| Feb 15, 202310-K | Annual report |
13 current reports (8-K) not listed; the year is on EDGAR.
2022 · 3 filings — 3 × 8-K
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 70 filings — 59 × 4, 6 × SCHEDULE 13G/A, 3 × 3 and 2 other forms
| Filed | What it is |
|---|---|
| Sep 16, 20264 | Insider transaction (Form 4) |
| Sep 16, 20263 | Initial insider holdings (Form 3) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 4, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 7, 2026SCHEDULE 13G/A | Other filings |
| Aug 7, 2026SCHEDULE 13G/A | Other filings |
| May 29, 2026SD | Specialized disclosure (conflict minerals) |
| May 26, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 14, 2026SCHEDULE 13G/A | Other filings |
| May 14, 2026SCHEDULE 13G/A | Other filings |
The newest 25 of 70 shown; the full year is on EDGAR.
2025 · 68 filings — 50 × 4, 4 × 144, 4 × 424B2 and 6 other forms
| Filed | What it is |
|---|---|
| Dec 2, 2025424B2 | Prospectus supplement |
| Dec 1, 2025FWP | Free writing prospectus |
| Dec 1, 2025424B2 | Prospectus supplement |
| Nov 24, 2025144 | Notice of proposed sale (Form 144) |
| Nov 13, 2025SCHEDULE 13G | Other filings |
| Oct 27, 2025144 | Notice of proposed sale (Form 144) |
| Sep 22, 2025144 | Notice of proposed sale (Form 144) |
| Sep 12, 2025144 | Notice of proposed sale (Form 144) |
| Sep 12, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Sep 3, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
| Aug 13, 2025SCHEDULE 13G | Other filings |
| Jun 6, 2025SCHEDULE 13G/A | Other filings |
| Jun 5, 2025424B2 | Prospectus supplement |
| Jun 3, 2025FWP | Free writing prospectus |
| Jun 3, 20254 | Insider transaction (Form 4) |
| Jun 3, 2025424B2 | Prospectus supplement |
| May 30, 20254 | Insider transaction (Form 4) |
The newest 25 of 68 shown; the full year is on EDGAR.
2024 · 82 filings — 47 × 4, 8 × 144, 8 × SC 13G/A and 8 other forms
| Filed | What it is |
|---|---|
| Nov 12, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 8, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 8, 2024424B3 | Prospectus |
| Nov 7, 2024FWP | Free writing prospectus |
| Nov 6, 20244 | Insider transaction (Form 4) |
| Nov 6, 2024144 | Notice of proposed sale (Form 144) |
| Nov 5, 2024144 | Notice of proposed sale (Form 144) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Oct 22, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Oct 22, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Sep 13, 2024424B3 | Prospectus |
| Sep 12, 2024FWP | Free writing prospectus |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Sep 4, 20244 | Insider transaction (Form 4) |
| Aug 20, 20244 | Insider transaction (Form 4) |
| Aug 19, 20244 | Insider transaction (Form 4) |
| Aug 19, 20244 | Insider transaction (Form 4) |
| Aug 19, 20244 | Insider transaction (Form 4) |
| Aug 15, 20244 | Insider transaction (Form 4) |
The newest 25 of 82 shown; the full year is on EDGAR.
2023 · 114 filings — 67 × 4, 17 × 3, 8 × 424B3 and 12 other forms
Counted, not listed; the year is on EDGAR.
2022 · 26 filings — 7 × 3, 4 × CORRESP, 4 × UPLOAD and 9 other forms
Counted, not listed; the year is on EDGAR.
About this data#
GE HealthCare Technologies Inc. Common Stock (GEHC) has 442 filings on EDGAR going back to 2022: 4 annual reports, 11 quarterly reports and 55 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 22, 2026, furnished a press release headed “GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors”. Over the last 13 months insiders sold nothing and bought $6.4M in 8 purchases; 71 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been GE HealthCare Technologies Inc. Common Stock, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read GEHC's latest 10-K?
- GEHC's latest annual report, a 10-K, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did GEHC last file an 8-K?
- On Sep 22, 2026 it furnished a press release headed “GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 29, 2026.
- Are GEHC insiders buying or selling?
- Over the last 13 months insiders sold nothing and bought $6.4M in 8 purchases; 71 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has GEHC made?
- 442 filings are on EDGAR under the registrant records that have been GE HealthCare Technologies Inc. Common Stock, going back to 2022; 268 of them are insider ownership forms (Forms 3, 4, 5 and 144).